| Primary |
| Hypertension |
27.3% |
| Product Used For Unknown Indication |
20.2% |
| Drug Use For Unknown Indication |
8.1% |
| Atrial Fibrillation |
7.1% |
| Gout |
5.1% |
| Type 2 Diabetes Mellitus |
5.1% |
| Chronic Hepatitis C |
3.0% |
| Coronary Artery Disease |
3.0% |
| Peripheral Arterial Occlusive Disease |
3.0% |
| Cardiac Failure |
2.0% |
| Depression |
2.0% |
| Glomerulonephritis Membranous |
2.0% |
| Oedema Peripheral |
2.0% |
| Pain In Extremity |
2.0% |
| Pulmonary Hypertension |
2.0% |
| Renal Impairment |
2.0% |
| Angina Pectoris |
1.0% |
| Arthralgia |
1.0% |
| Benign Prostatic Hyperplasia |
1.0% |
| Chronic Obstructive Pulmonary Disease |
1.0% |
|
| Renal Failure Acute |
22.2% |
| Vertigo |
11.1% |
| Vomiting |
11.1% |
| Inappropriate Antidiuretic Hormone Secretion |
7.4% |
| Atrial Fibrillation |
3.7% |
| Cardiac Failure |
3.7% |
| Diabetes Mellitus |
3.7% |
| Drug Abuse |
3.7% |
| Gout |
3.7% |
| Hypotension |
3.7% |
| Inappropriate Schedule Of Drug Administration |
3.7% |
| Pancreatitis Acute |
3.7% |
| Renal Failure |
3.7% |
| Syncope |
3.7% |
| Treatment Noncompliance |
3.7% |
| Ultrasound Antenatal Screen Abnormal |
3.7% |
| Vision Blurred |
3.7% |
|
| Secondary |
| Product Used For Unknown Indication |
25.0% |
| Drug Use For Unknown Indication |
19.4% |
| Hypertension |
15.0% |
| Drug Abuse |
13.2% |
| Cardiac Failure |
6.0% |
| Chronic Obstructive Pulmonary Disease |
2.1% |
| Atrial Fibrillation |
1.9% |
| Type 2 Diabetes Mellitus |
1.8% |
| Coronary Artery Disease |
1.7% |
| Tachyarrhythmia |
1.7% |
| Myocardial Ischaemia |
1.6% |
| Pain |
1.6% |
| Premedication |
1.4% |
| Hyperlipidaemia |
1.3% |
| Diabetes Mellitus |
1.2% |
| Hyperuricaemia |
1.2% |
| Rheumatoid Arthritis |
1.0% |
| Sepsis |
1.0% |
| Depression |
1.0% |
| Glomerulonephritis |
1.0% |
|
| Renal Failure Acute |
17.5% |
| Urine Colour Abnormal |
12.0% |
| Hyponatraemia |
7.2% |
| Rhabdomyolysis |
6.6% |
| Syncope |
6.6% |
| Vomiting |
6.6% |
| Stevens-johnson Syndrome |
6.0% |
| Transaminases Increased |
6.0% |
| Suicide Attempt |
4.8% |
| Strabismus |
3.6% |
| Hypotension |
3.0% |
| Renal Failure |
3.0% |
| Talipes |
3.0% |
| Pancreatitis Acute |
2.4% |
| Premature Rupture Of Membranes |
2.4% |
| Constipation |
1.8% |
| Deep Vein Thrombosis |
1.8% |
| Drug Interaction |
1.8% |
| Loss Of Consciousness |
1.8% |
| Pancreatitis |
1.8% |
|
| Concomitant |
| Hypertension |
21.4% |
| Product Used For Unknown Indication |
18.1% |
| Drug Use For Unknown Indication |
10.8% |
| Prophylaxis |
5.9% |
| Cardiac Failure |
5.8% |
| Atrial Fibrillation |
5.2% |
| Rheumatoid Arthritis |
4.4% |
| Diabetes Mellitus |
3.5% |
| Type 2 Diabetes Mellitus |
3.4% |
| Pain |
3.0% |
| Pulmonary Arterial Hypertension |
2.4% |
| Chronic Obstructive Pulmonary Disease |
2.4% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.2% |
| Coronary Artery Disease |
2.2% |
| Thrombosis Prophylaxis |
1.8% |
| B-cell Lymphoma |
1.7% |
| Colorectal Cancer Metastatic |
1.5% |
| Pneumonia |
1.5% |
| Metastatic Renal Cell Carcinoma |
1.4% |
| Depression |
1.4% |
|
| Renal Failure |
9.0% |
| Pneumonia |
8.4% |
| Thrombocytopenia |
7.8% |
| Renal Failure Acute |
6.6% |
| Sepsis |
6.3% |
| Urinary Tract Infection |
6.3% |
| Vomiting |
6.3% |
| Syncope |
4.8% |
| Cardiac Failure |
4.5% |
| Drug Interaction |
4.5% |
| Myocardial Infarction |
4.5% |
| Respiratory Failure |
4.5% |
| Death |
3.6% |
| Weight Decreased |
3.6% |
| Autoimmune Hepatitis |
3.3% |
| Hypoglycaemia |
3.3% |
| Pseudomembranous Colitis |
3.3% |
| Ventricular Fibrillation |
3.3% |
| Gastrointestinal Haemorrhage |
3.0% |
| Pleural Effusion |
3.0% |
|
| Interacting |
| Hypertension |
40.3% |
| Type 2 Diabetes Mellitus |
10.7% |
| Drug Use For Unknown Indication |
6.9% |
| Hyperlipidaemia |
6.0% |
| Pain |
4.7% |
| Atrial Fibrillation |
3.9% |
| Tachyarrhythmia |
3.9% |
| Glaucoma |
3.4% |
| Ischaemic Heart Disease Prophylaxis |
3.4% |
| Prophylaxis Against Gastrointestinal Ulcer |
3.0% |
| Rheumatoid Arthritis |
2.6% |
| Cardiac Failure |
1.7% |
| Bronchial Carcinoma |
1.3% |
| Coronary Artery Disease |
1.3% |
| Immunosuppressant Drug Therapy |
1.3% |
| Iron Deficiency |
1.3% |
| Osteoporosis |
1.3% |
| Restlessness |
1.3% |
| Gastritis Haemorrhagic |
0.9% |
| Hypothyroidism |
0.9% |
|
| Renal Failure Acute |
50.0% |
| Transaminases Increased |
11.5% |
| Inappropriate Antidiuretic Hormone Secretion |
7.7% |
| Vomiting |
7.7% |
| Drug Interaction |
3.8% |
| Renal Failure |
3.8% |
| Thrombocytopenia |
3.8% |
| Urinary Retention |
3.8% |
| Weight Decreased |
3.8% |
| Weight Increased |
3.8% |
|
